Request Deal Involvement

BOLD and Evonik led a €35m funding round in Abolis Biotechnologies.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Spayne Lindsay & Co

financial advisors

Spayne Lindsay & Co

Ulysse Communication

pr advisors

Ulysse Communication

McDermott Will & Emery

legal advisors

McDermott Will & Emery

or

Principals

ABOLIS BIOTECHNOLOGIES

target

ABOLIS BIOTECHNOLOGIES

EVONIK VENTURE CAPITAL

bidder

EVONIK VENTURE CAPITAL

BUSINESS OPPORTUNITIES FOR L'ORÉAL DEVELOPMENT (BOLD)

bidder

BUSINESS OPPORTUNITIES FOR L'ORÉAL DEVELOPMENT (BOLD)

CLAY CAPITAL

bidder

CLAY CAPITAL

LIBERSET

bidder

LIBERSET

DEEPTECH & CLIMATE FONDS

bidder

DEEPTECH & CLIMATE FONDS

ICOS CAPITAL

bidder

ICOS CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - BOLD and Evonik led a €35m funding round in Abolis Biotechnologies.